In yesterday’s Wall Street session, Cronos Group Inc. (NASDAQ:CRON) shares traded at $1.78, down -1.66% from the previous session.
CRON stock price is now -3.29% away from the 50-day moving average and -22.24% away from the 200-day moving average. The market capitalization of the company currently stands at $898.28M.
With the price target of $3, Bernstein recently initiated with Mkt Perform rating for Cronos Group Inc. (NASDAQ: CRON).
In other news, ADLER JASON MARC, Director bought 37,500 shares of the company’s stock on May 30. The stock was bought for $65,074 at an average price of $1.74. Upon completion of the transaction, the Director now directly owns 1,402,304 shares in the company, valued at $2.5 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 25, Director ADLER JASON MARC bought 100,000 shares of the business’s stock. A total of $179,650 was incurred on buying the stock at an average price of $1.80. This leaves the insider owning 1,376,054 shares of the company worth $2.45 million. A total of 46.85% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in CRON stock. A new stake in Cronos Group Inc. shares was purchased by ETF MANAGERS GROUP, LLC during the first quarter worth $9,840,000. ERGOTELES LLC invested $903,000 in shares of CRON during the first quarter. In the first quarter, AXS INVESTMENTS LLC acquired a new stake in Cronos Group Inc. valued at approximately $797,000. TIMELO INVESTMENT MANAGEMENT INC. acquired a new stake in CRON for approximately $343,000. MARATHON TRADING INVESTMENT MANAGEMENT LLC purchased a new stake in CRON valued at around $180,000 in the second quarter. In total, there are 219 active investors with 11.30% ownership of the company’s stock.
On Thursday morning Cronos Group Inc. (NASDAQ: CRON) stock kicked off with the opening price of $1.8200. During the past 12 months, Cronos Group Inc. has had a low of $1.66 and a high of $3.62. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 31.40, and a quick ratio of 29.90. The fifty day moving average price for CRON is $1.8410 and a two-hundred day moving average price translates $2.2838 for the stock.
The latest earnings results from Cronos Group Inc. (NASDAQ: CRON) was released for Mar, 2023. The company reported revenue of $20.14 million for the quarter, compared to $25.03 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -19.53 percent.
Cronos Group Inc.(CRON) Company Profile
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones brand in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
